Roche Begins $5.7 Billion Hostile Takeover Bid for Illumina

Roche Holding AG began its $5.7 billion hostile takeover offer for Illumina Inc., even as investors signaled they expect the Swiss drugmaker to raise its bid for the gene-mapping company.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.